Safety Alerts & Recalls

What does this mean?

This recall for Motrin IB was issued at a warehouse and retail level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. If you take Motrin IB 200 mg and are concerned about this recall, you should follow up with your doctor or pharmacist.

McNeil Healthcare Recalls Additional Lot of Motrin IB

McNeil Healthcare, LLC has recalled another lot of Motrin: Motrin IB (Ibuprofen) Caplets, 200mg, Pain Reliever/Fever Reduce, available over-the-counter (OTC) in bottles of 24 Coated Caplets. Lot number SDA149 has been recalled because this lot failed the manufacturer routine tests that measure the capsules' ability to dissolve.

This recall for lot number SDA149 of Motrin IB Caplets, 200 mg in bottles of 24 caplets is in addition to the previous McNeil recalls alerts for Motrin IB products.

To view the FDA notice about this recall, please visit: more information here

Source: FDA
Publication Date: 2010-07-30
Last Updated: 2010-08-01

Visit the medication page for the following drugs:

Share your story Share your story! Tell us how MediGuard has helped you or someone you love. Mobile graphic Download the MediGuard Mobile App to manage your prescription and over-the-counter medications, for free. Registration Info Taking multiple medications puts you at risk for possible drug-drug interactions Registration Info Monitor the medical treatment of you and your loved ones.